Ureaplasma parvum causes hyperammonemia in a pharmacologically immunocompromised murine model

X. Wang, K. E. Greenwood-Quaintance, M. J. Karau, D. R. Block, Jayawant Mandrekar, S. A. Cunningham, J. M. Mallea, Robin Patel

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

A relationship between hyperammonemia and Ureaplasma infection has been shown in lung transplant recipients. We have demonstrated that Ureaplasma urealyticum causes hyperammonemia in a novel immunocompromised murine model. Herein, we determined whether Ureaplasma parvum can do the same. Male C3H mice were given mycophenolate mofetil, tacrolimus, and prednisone for 7 days, and then challenged with U. parvum intratracheally (IT) and/or intraperitoneally (IP), while continuing immunosuppression over 6 days. Plasma ammonia concentrations were determined and compared using Wilcoxon rank-sum tests. Plasma ammonia concentrations of immunosuppressed mice challenged IT/IP with spent broth (median, 188 μmol/L; range, 102–340 μmol/L) were similar to those of normal (median, 226 μmol/L; range, 154–284 μmol/L, p > 0.05), uninfected immunosuppressed (median, 231 μmol/L; range, 122–340 μmol/L, p > 0.05), and U. parvum IT/IP challenged immunocompetent (median, 226 μmol/L; range, 130–330 μmol/L, p > 0.05) mice. Immunosuppressed mice challenged with U. parvum IT/IP (median 343 μmol/L; range 136–1,000 μmol/L) or IP (median 307 μmol/L; range 132–692 μmol/L) had higher plasma ammonia concentrations than those challenged IT/IP with spent broth (p < 0.001). U. parvum can cause hyperammonemia in pharmacologically immunocompromised mice.

Original languageEnglish (US)
Pages (from-to)1-6
Number of pages6
JournalEuropean Journal of Clinical Microbiology and Infectious Diseases
DOIs
StateAccepted/In press - Oct 28 2016

Fingerprint

Ureaplasma
Hyperammonemia
Ammonia
Nonparametric Statistics
Ureaplasma Infections
Ureaplasma urealyticum
Mycophenolic Acid
Inbred C3H Mouse
Tacrolimus
Prednisone
Immunosuppression
Lung

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Ureaplasma parvum causes hyperammonemia in a pharmacologically immunocompromised murine model. / Wang, X.; Greenwood-Quaintance, K. E.; Karau, M. J.; Block, D. R.; Mandrekar, Jayawant; Cunningham, S. A.; Mallea, J. M.; Patel, Robin.

In: European Journal of Clinical Microbiology and Infectious Diseases, 28.10.2016, p. 1-6.

Research output: Contribution to journalArticle

Wang, X. ; Greenwood-Quaintance, K. E. ; Karau, M. J. ; Block, D. R. ; Mandrekar, Jayawant ; Cunningham, S. A. ; Mallea, J. M. ; Patel, Robin. / Ureaplasma parvum causes hyperammonemia in a pharmacologically immunocompromised murine model. In: European Journal of Clinical Microbiology and Infectious Diseases. 2016 ; pp. 1-6.
@article{70cd252f9ebd43beb189ce4cb54dfdae,
title = "Ureaplasma parvum causes hyperammonemia in a pharmacologically immunocompromised murine model",
abstract = "A relationship between hyperammonemia and Ureaplasma infection has been shown in lung transplant recipients. We have demonstrated that Ureaplasma urealyticum causes hyperammonemia in a novel immunocompromised murine model. Herein, we determined whether Ureaplasma parvum can do the same. Male C3H mice were given mycophenolate mofetil, tacrolimus, and prednisone for 7 days, and then challenged with U. parvum intratracheally (IT) and/or intraperitoneally (IP), while continuing immunosuppression over 6 days. Plasma ammonia concentrations were determined and compared using Wilcoxon rank-sum tests. Plasma ammonia concentrations of immunosuppressed mice challenged IT/IP with spent broth (median, 188 μmol/L; range, 102–340 μmol/L) were similar to those of normal (median, 226 μmol/L; range, 154–284 μmol/L, p > 0.05), uninfected immunosuppressed (median, 231 μmol/L; range, 122–340 μmol/L, p > 0.05), and U. parvum IT/IP challenged immunocompetent (median, 226 μmol/L; range, 130–330 μmol/L, p > 0.05) mice. Immunosuppressed mice challenged with U. parvum IT/IP (median 343 μmol/L; range 136–1,000 μmol/L) or IP (median 307 μmol/L; range 132–692 μmol/L) had higher plasma ammonia concentrations than those challenged IT/IP with spent broth (p < 0.001). U. parvum can cause hyperammonemia in pharmacologically immunocompromised mice.",
author = "X. Wang and Greenwood-Quaintance, {K. E.} and Karau, {M. J.} and Block, {D. R.} and Jayawant Mandrekar and Cunningham, {S. A.} and Mallea, {J. M.} and Robin Patel",
year = "2016",
month = "10",
day = "28",
doi = "10.1007/s10096-016-2827-1",
language = "English (US)",
pages = "1--6",
journal = "European Journal of Clinical Microbiology and Infectious Diseases",
issn = "0934-9723",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Ureaplasma parvum causes hyperammonemia in a pharmacologically immunocompromised murine model

AU - Wang, X.

AU - Greenwood-Quaintance, K. E.

AU - Karau, M. J.

AU - Block, D. R.

AU - Mandrekar, Jayawant

AU - Cunningham, S. A.

AU - Mallea, J. M.

AU - Patel, Robin

PY - 2016/10/28

Y1 - 2016/10/28

N2 - A relationship between hyperammonemia and Ureaplasma infection has been shown in lung transplant recipients. We have demonstrated that Ureaplasma urealyticum causes hyperammonemia in a novel immunocompromised murine model. Herein, we determined whether Ureaplasma parvum can do the same. Male C3H mice were given mycophenolate mofetil, tacrolimus, and prednisone for 7 days, and then challenged with U. parvum intratracheally (IT) and/or intraperitoneally (IP), while continuing immunosuppression over 6 days. Plasma ammonia concentrations were determined and compared using Wilcoxon rank-sum tests. Plasma ammonia concentrations of immunosuppressed mice challenged IT/IP with spent broth (median, 188 μmol/L; range, 102–340 μmol/L) were similar to those of normal (median, 226 μmol/L; range, 154–284 μmol/L, p > 0.05), uninfected immunosuppressed (median, 231 μmol/L; range, 122–340 μmol/L, p > 0.05), and U. parvum IT/IP challenged immunocompetent (median, 226 μmol/L; range, 130–330 μmol/L, p > 0.05) mice. Immunosuppressed mice challenged with U. parvum IT/IP (median 343 μmol/L; range 136–1,000 μmol/L) or IP (median 307 μmol/L; range 132–692 μmol/L) had higher plasma ammonia concentrations than those challenged IT/IP with spent broth (p < 0.001). U. parvum can cause hyperammonemia in pharmacologically immunocompromised mice.

AB - A relationship between hyperammonemia and Ureaplasma infection has been shown in lung transplant recipients. We have demonstrated that Ureaplasma urealyticum causes hyperammonemia in a novel immunocompromised murine model. Herein, we determined whether Ureaplasma parvum can do the same. Male C3H mice were given mycophenolate mofetil, tacrolimus, and prednisone for 7 days, and then challenged with U. parvum intratracheally (IT) and/or intraperitoneally (IP), while continuing immunosuppression over 6 days. Plasma ammonia concentrations were determined and compared using Wilcoxon rank-sum tests. Plasma ammonia concentrations of immunosuppressed mice challenged IT/IP with spent broth (median, 188 μmol/L; range, 102–340 μmol/L) were similar to those of normal (median, 226 μmol/L; range, 154–284 μmol/L, p > 0.05), uninfected immunosuppressed (median, 231 μmol/L; range, 122–340 μmol/L, p > 0.05), and U. parvum IT/IP challenged immunocompetent (median, 226 μmol/L; range, 130–330 μmol/L, p > 0.05) mice. Immunosuppressed mice challenged with U. parvum IT/IP (median 343 μmol/L; range 136–1,000 μmol/L) or IP (median 307 μmol/L; range 132–692 μmol/L) had higher plasma ammonia concentrations than those challenged IT/IP with spent broth (p < 0.001). U. parvum can cause hyperammonemia in pharmacologically immunocompromised mice.

UR - http://www.scopus.com/inward/record.url?scp=84992724226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992724226&partnerID=8YFLogxK

U2 - 10.1007/s10096-016-2827-1

DO - 10.1007/s10096-016-2827-1

M3 - Article

SP - 1

EP - 6

JO - European Journal of Clinical Microbiology and Infectious Diseases

JF - European Journal of Clinical Microbiology and Infectious Diseases

SN - 0934-9723

ER -